scholarly journals Prenatal diagnosis of partial monosomy 2q (2q37.3→qter) and partial trisomy 10q (10q24.31→qter) of paternal origin associated with increased nuchal translucency and abnormal maternal serum screening results

2020 ◽  
Vol 59 (5) ◽  
pp. 758-762
Author(s):  
Chih-Ping Chen ◽  
Jui-Der Liou ◽  
Kok-Min Seow ◽  
Schu-Rern Chern ◽  
Peih-Shan Wu ◽  
...  
Author(s):  
Jen-Huang Chen ◽  
Te-Yao Hsu ◽  
Chia-Yu Ou ◽  
Lih-Feng Chang ◽  
Shiuh-Young Chang ◽  
...  

1978 ◽  
Vol 25 (3) ◽  
pp. 619-629 ◽  
Author(s):  
Barbara F. Crandall ◽  
Thomas B. Lebherz ◽  
Raimund Freihube

Ultrasound ◽  
2009 ◽  
Vol 17 (3) ◽  
pp. 167-171
Author(s):  
Debbie L Nisbet ◽  
Andrew McLennan

Prenatal screening for Down syndrome should be offered to all pregnant women. The screening option chosen will be influenced by maternal preference, local availability of tests, and the gestation at which the pregnant woman presents. Screening tests take into account the effect of maternal age on Down syndrome risk. The combined first trimester screen using nuchal translucency and first trimester maternal serum screening can achieve a detection rate for Down syndrome of 90% with a 5% false positive rate, when performed by appropriately trained individuals. Midtrimester maternal serum screening is a good screening option for women unable to undergo the combined first trimester screen.


Sign in / Sign up

Export Citation Format

Share Document